Oxcarbazepine Market Report – Research, Industry Analysis Reports and Market Demands

Global Oxcarbazepine Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Oxcarbazepine Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Oxcarbazepine Market Size Growth Rate by Type
- 1.4.2 Tablets (150mg, 300mg, 600mg)
- 1.4.3 Oral Suspension
1.5 Market by Application
- 1.5.1 Global Oxcarbazepine Market Size Growth Rate by Application
- 1.5.2 Pediatric Use (Aged 2-4 years, 4-16 years)
- 1.5.3 Adult Use
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Oxcarbazepine Market Size
- 2.1.1 Global Oxcarbazepine Revenue 2014-2025
- 2.1.2 Global Oxcarbazepine Sales 2014-2025
2.2 Oxcarbazepine Growth Rate by Regions
- 2.2.1 Global Oxcarbazepine Sales by Regions
- 2.2.2 Global Oxcarbazepine Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Oxcarbazepine Sales by Manufacturers
- 3.1.1 Oxcarbazepine Sales by Manufacturers
- 3.1.2 Oxcarbazepine Sales Market Share by Manufacturers
3.2 Oxcarbazepine Revenue by Manufacturers
- 3.2.1 Oxcarbazepine Revenue by Manufacturers (2014-2019)
- 3.2.2 Oxcarbazepine Revenue Share by Manufacturers (2014-2019)
3.3 Oxcarbazepine Price by Manufacturers
3.4 Oxcarbazepine Manufacturing Base Distribution, Product Types
- 3.4.1 Oxcarbazepine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oxcarbazepine Product Type
- 3.4.3 Date of International Manufacturers Enter into Oxcarbazepine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

4.1 Global Oxcarbazepine Sales by Type
4.2 Global Oxcarbazepine Revenue by Type
4.3 Oxcarbazepine Price by Type

5 Breakdown Data by Application

5.1 Overview
5.2 Global Oxcarbazepine Breakdown Data by Application

6 North America

6.1 North America Oxcarbazepine by Country
- 6.1.1 North America Oxcarbazepine Sales by Country
- 6.1.2 North America Oxcarbazepine Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Oxcarbazepine by Type
6.3 North America Oxcarbazepine by Application

7 Europe

7.1 Europe Oxcarbazepine by Country
- 7.1.1 Europe Oxcarbazepine Sales by Country
- 7.1.2 Europe Oxcarbazepine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Oxcarbazepine by Type
7.3 Europe Oxcarbazepine by Application

8 Asia Pacific

8.1 Asia Pacific Oxcarbazepine by Region
- 8.1.1 Asia Pacific Oxcarbazepine Sales by Region
- 8.1.2 Asia Pacific Oxcarbazepine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Thailand
- 8.1.10 Malaysia
- 8.1.11 Philippines
- 8.1.12 Vietnam
8.2 Asia Pacific Oxcarbazepine by Type
8.3 Asia Pacific Oxcarbazepine by Application

9 Central & South America

9.1 Central & South America Oxcarbazepine by Country
- 9.1.1 Central & South America Oxcarbazepine Sales by Country
- 9.1.2 Central & South America Oxcarbazepine Revenue by Country
- 9.1.3 Brazil
9.2 Central & South America Oxcarbazepine by Type
9.3 Central & South America Oxcarbazepine by Application

10 Middle East and Africa

10.1 Middle East and Africa Oxcarbazepine by Country
- 10.1.1 Middle East and Africa Oxcarbazepine Sales by Country
- 10.1.2 Middle East and Africa Oxcarbazepine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 GCC Countries
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Oxcarbazepine by Type
10.3 Middle East and Africa Oxcarbazepine by Application

11 Company Profiles

12 Future Forecast

12.1 Oxcarbazepine Market Forecast by Regions
- 12.1.1 Global Oxcarbazepine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Oxcarbazepine Revenue Forecast by Regions 2019-2025
12.2 Oxcarbazepine Market Forecast by Type
- 12.2.1 Global Oxcarbazepine Sales Forecast by Type 2019-2025
- 12.2.2 Global Oxcarbazepine Revenue Forecast by Type 2019-2025
12.3 Oxcarbazepine Market Forecast by Application
12.4 North America Oxcarbazepine Forecast
12.5 Europe Oxcarbazepine Forecast
12.6 Asia Pacific Oxcarbazepine Forecast
12.7 Central & South America Oxcarbazepine Forecast
12.8 Middle East and Africa Oxcarbazepine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Oxcarbazepine Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Oxcarbazepine, sold under the brand name Trileptal among others, is a medication used to treat epilepsy and bipolar disorder. It is a structural derivative of carbamazepine, with an extra oxygen atom to the benzylcarboxamide group. The presence of an extra oxygen atom in the structure reduces the susceptibility of the drug to hepatic metabolism, leading to prolonged pharmacological action or half life of the drug.
The global Oxcarbazepine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oxcarbazepine market based on company, product type, end user and key regions.

This report studies the global market size of Oxcarbazepine in key regions like North America, Europe, China and India, focuses on the consumption of Oxcarbazepine in these regions.
This research report categorizes the global Oxcarbazepine market by top players/brands, region, type and end user. This report also studies the global Oxcarbazepine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis (Trileptal)
Supernus Pharmaceuticals (Oxtellar XR)
Sun Pharm
Ranbaxy Pharmaceuticals
Jubilant Generics
Taro Pharmaceuticals
Mylan
Stada Group
Glenmark Pharmaceuticals
ANI Pharmaceuticals
Teva Pharmaceutical
Roxane Laboratories
Nobelpharma
Apotex
Nexgen pharma
Amneal Pharmaceuticals
Hikma Pharmaceuticals
Jamp Pharma
Neuraxpharm
Orion Corporation
Sihuan Pharm
Humanwell Healthcare
Huikang Pharmaceutical

Oxcarbazepine market size by Type
Tablets (150mg, 300mg, 600mg)
Oral Suspension

Oxcarbazepine market size by Applications
Pediatric Use (Aged 2-4 years, 4-16 years)
Adult Use

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Oxcarbazepine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oxcarbazepine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oxcarbazepine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oxcarbazepine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Oxcarbazepine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Unit). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oxcarbazepine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.